Stock data
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported net income of -US$11.72M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$11.92M | -US$11.72M | — |
| 2024 | — | — | -US$7.70M | -US$9.14M | — |
| 2023 | — | — | -US$5.89M | -US$6.59M | — |
| 2022 | — | — | -US$2.55M | -US$3.03M | — |
| 2021 | — | — | -US$1.74M | -US$1.15M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.15M | — |
| 2026-03-31 | — | -US$2.15M | — |
| 2025-12-31 | — | -US$2.61M | — |
| 2025-09-30 | — | -US$2.35M | — |
| 2025-06-30 | — | -US$3.71M | — |
| 2025-03-31 | — | -US$3.05M | — |
| 2024-12-31 | — | -US$1.60M | — |
| 2024-09-30 | — | -US$3.78M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.